TABLE 2.
Genotypic results (SEQ→OLA) (n)b | No. of codons with RT amino acid mutation which confers resistance to:
|
No. of codons with PR amino acid mutation which confers resistance to PR inhibitors
|
||||||
---|---|---|---|---|---|---|---|---|
NRT inhibitorsa
|
NNRT inhibitorsa
|
|||||||
Q151M | M184V | T215Y | K103N | Y181C | D30N | V82A | L90M | |
HIV-1 non-B subtypes and RF samples | ||||||||
MT (SEQ)→MT (OLA) (29) | 0 | 7 | 4 | 12 | 1 | 0 | 1 | 4 |
MT (SEQ)→WT (OLA) (0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MT (SEQ)→INDET (OLA) (3) | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 |
WT (SEQ)→WT (OLA) (103) | 14 | 11 | 6 | 9 | 12 | 21 | 14 | 16 |
WT (SEQ)→MT (OLA) (5) | 0 | 0 | 0 | 1 | 3 | 0 | 0 | 1 |
WT (SEQ)→INDET (OLA) (16) | 1 | 1 | 2 | 0 | 3 | 1 | 7 | 1 |
Total (156) | 15 | 21 | 12 | 23 | 19 | 22 | 22 | 22 |
HIV-1 subtype B samples | ||||||||
MT (SEQ)→MT (OLA) (81) | 10 | 21 | 8 | 16 | 7 | 2 | 5 | 12 |
MT (SEQ)→WT (OLA) (0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MT (SEQ)→INDET (OLA) (5) | 0 | 0 | 1 | 1 | 0 | 0 | 3 | 0 |
WT (SEQ)→WT (OLA) (193) | 27 | 15 | 14 | 18 | 18 | 40 | 34 | 27 |
WT (SEQ)→MT (OLA) (34) | 1 | 7 | 2 | 2 | 17 | 1 | 1 | 3 |
WT (SEQ)→INDET (OLA) (8) | 1 | 1 | 2 | 1 | 2 | 0 | 0 | 1 |
Total (321) | 39 | 44 | 27 | 38 | 44 | 43 | 43 | 43 |
NRT, nucleoside reverse transcriptase; NNRT, nonnucleoside reverse transcriptase.
MT, mutant; WT, wild type; INDET, indeterminate (negative for both wild-type and mutant genotypes).